Printer-friendly version
V.A.C. VERAFLO CLEANSE CHOICE™ Dressing features a three-layer design that facilitates the removal of thick wound exudate, such as thick fibrin (wet slough) and other infectious material.
• Provides a wound cleansing option for clinicians when surgical debridement must be delayed or is not possible or appropriate
• Provides "mechanical" movement at the wound surface in combination with cyclic delivery and dwell of topical solutions
• Three-layer design: contact layer with a pattern of 1cm through holes, two cover layers (without holes) to provide application options for wounds with varying depths
• Cover layer designed to capture large wound exudate particles before they enter tubing
• Wound contact layer's large holes enhance conformability to the wound bed
V.A.C. VERAFLO CLEANSE CHOICE™ Dressing is for use with V.A.C. VERAFLO™ Therapy in wounds with thick wound exudate, such as fibrin, slough or infectious material.
Do not cut dressing over wound bed.
Do not pack foam into wound.
Do not use the wound contact layer with holes in tunnels or undermined areas.
| Acrylic adhesive drape | |
| Adhesive border dressing | |
| Alternative interface dressing | |
| Antimicrobial | |
| Compatible w/ topicals | |
| Flat drain kit | |
| Foam interface dressing | ● |
| Gauze interface dressing | |
| Interface intact when saturated | ● |
| Kit components available separately | |
| Moisture vapor permeable interface | |
| Round drain kit | |
| Silicone acrylic adhesive drape | |
| Usable on closed wounds | |
| Usable on open wounds | ● |
Acute Wounds
Burns
Cavity Wounds
Chronic Wounds
Deep Wounds
Diabetic Foot
Infected Wounds
Moderate/Highly Exudating Wounds
Non/Minimally Exudating Wounds
Pressure Ulcers
Sloughy Wounds
Venous Ulcers
1. Wound Preparation and Application of 3M™ Cavilon™ No Sting Barrier Film
Ensure debridement of all necrotic, non-viable tissue, including bone, eschar, or hardened slough, as prescribed by treating physician. Perform thorough wound and periwound area cleaning per physician order or institution protocol prior to each dressing application. Skin should be clean and dry prior to application of 3M™ Cavilon™ No Sting Barrier Film. Wipe uniform coating of film over the entire area of concern. Allow to thoroughly dry before applying drape.
2. Placement of Wound Contact Layer
Protect sensitive structures, vessels, and organs as needed. Assess wound dimensions and pathology, including the presence of undermining or tunnels. Cut the thin or thick cover layer of foam to fill explored tunnels and undermining. Be sure foam in tunnels makes contact with cover layer. Cut wound contact layer as needed to cover the entire wound bed and gently place in wound.
3. Filling the Wound with the Cover Layer
Cut thick or thin cover layer as needed to fill the wound depth and gently place in the wound on top of the wound contact layer.
4. V.A.C.® Advanced Drape Application
Trim the drape to cover the foam and at least an additional 3cm-5cm border of intact periwound tissue. Remove layer #1 to expose the adhesive and apply to cover layer and intact skin while ensuring skin wrinkles and folds are smoothed. Remove layer #2 and pat the drape to ensure an occlusive seal. Remove the ruler/handling bars.
5. V.A.C. VERAT.R.A.C.™ Pad Placement
Choose pad application site. Give particular consideration to tubing positioning to allow for optimal flow, and avoid placement over bony prominences or within creases in the tissue. Cut an approximately 2.5cm hole through the drape to affix V.A.C. VERAT.R.A.C.™ Pad. Remove both backing layers 1 and 2 to expose adhesive. Position and apply V.A.C. VERAT.R.A.C.™ Pad over the 2.5cm hole. Pull back on blue tab to remove pad stabilization layer.
NOTE:
Dressings should be changed every 48-72 hours, but no less than three times per week, with frequency adjusted by the clinician as appropriate.
Wound contact layer: 0.8cm thick
Thin cover layer: 0.8cm thick
Thick cover layer: 1.6cm thick
Acelity leverages the strengths of Kinetic Concepts and Systagenix Wound Management to provide a trusted and complementary portfolio of advanced wound therapeutics for customers and patients in more than 90 countries worldwide.